Toggle light / dark theme

From abstract-looking cloud formations to roars of snow machines on ski slopes, the transformation of liquid water into solid ice touches many facets of life. Water’s freezing point is generally accepted to be 32 degrees Fahrenheit. But that is due to ice nucleation—impurities in everyday water raise its freezing point to this temperature. Now, researchers unveil a theoretical model that shows how specific structural details on surfaces can influence water’s freezing point.

A research team led by Prof. Meng Guowen and Prof. Han Fangming from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, together with Prof. Wei Bingqing from the University of Delaware, miniaturized line-filtering capacitors with “matryoshka doll” structure electrodes, providing a high-performance and space-saving solution for line-filtering applications.

The Tesla FSD V12.3 performs well in snowy conditions, demonstrating good acceleration, braking, and handling capabilities, as well as safety features such as pausing at intersections without stop signs.

Questions to inspire discussion.

How does the Tesla FSD V12.3 perform in snowy conditions?
—The Tesla FSD V12.3 performs well in snowy conditions, demonstrating good acceleration, braking, and handling capabilities.

Tesla FSD v12.3 in Austin, Texas demonstrates significant improvements in smoothness, confidence, and assertive driving, with better safety, natural stops, improved navigation, and a sense of understanding, showing promising long-term implications for Tesla.

Questions to inspire discussion.

What improvements does Tesla FSD v12.3 show in driving behavior?
—Tesla FSD v12.3 demonstrates significant improvements in smoothness, confidence, assertiveness, and handling of pedestrians and traffic obstacles, showcasing its potential for widespread adoption.

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg–Kimmel Institute for Cancer Immunotherapy.